ClearSign director granted 4,595 stock options
ClearSign Technologies Corp director Lou Basenese received a grant of stock options as part of his quarterly board compensation.
Rhea-AI Filing Summary
ClearSign Technologies Corp director Lou Basenese received a grant of stock options as part of his quarterly board compensation. On the grant date, he was awarded non-statutory options to purchase 4,595 shares of common stock at an exercise price of $3.67 per share.
The options were granted under ClearSign’s Amended and Restated 2021 Equity Incentive Plan pursuant to the company’s non-employee director compensation policy and became fully vested and exercisable immediately. Following this grant, Basenese holds 4,595 non-statutory stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,595 shares
Grant/Award
1 txn
Insider
Basenese Lou
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Statutory Stock Options | 4,595 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Statutory Stock Options — 4,595 contracts (Direct)
Footnotes (1)
- F1. As compensation for services as a non-employee director during the quarter ended June 30, 2026, the reporting person was granted non-statutory stock options to purchase 4,595 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date.
Key Figures
Options granted: 4,595 options
Exercise price: $3.67 per share
Underlying shares: 4,595 shares
+2 more
5 metrics
Options granted
4,595 options
Non-statutory stock options granted as non-employee director compensation for quarter ended June 30, 2026
Exercise price
$3.67 per share
Exercise price for the 4,595 non-statutory stock options
Underlying shares
4,595 shares
Common stock underlying the granted non-statutory options
Expiration date
June 29, 2036
Scheduled expiration of the granted stock options
Options held after grant
4,595 options
Total non-statutory stock options directly owned following this transaction
Key Terms
Non-Statutory Stock Options, Equity Incentive Plan, non-employee director compensation policy, vested and exercisable
4 terms
Non-Statutory Stock Options financial
"the reporting person was granted non-statutory stock options to purchase 4,595 shares of common stock"
Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.
Equity Incentive Plan financial
"under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
non-employee director compensation policy financial
"pursuant to the issuer's non-employee director compensation policy"
vested and exercisable financial
"These non-statutory stock options were immediately vested and exercisable on the grant date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ClearSign Technologies (CLIR) director Lou Basenese report in this Form 4?
Lou Basenese reported receiving a grant of non-statutory stock options as director compensation. He was awarded 4,595 options to purchase ClearSign common shares at a $3.67 exercise price, which vested and became exercisable immediately under the company’s 2021 equity incentive plan.
How many ClearSign (CLIR) stock options were granted to Lou Basenese?
Lou Basenese was granted 4,595 non-statutory stock options. Each option gives him the right to purchase one share of ClearSign common stock, providing potential future ownership if he chooses to exercise the options at the fixed $3.67 per-share price.
What is the exercise price and term of Lou Basenese’s ClearSign (CLIR) options?
The options have a $3.67 per-share exercise price and expire on June 29, 2036. This long expiration period gives Basenese extended time to decide whether to exercise and convert the 4,595 options into ClearSign common shares.
Were Lou Basenese’s ClearSign (CLIR) options immediately vested?
Yes, the 4,595 non-statutory stock options vested and became exercisable immediately on the grant date. This means Basenese can choose to exercise the options at any time before their June 29, 2036 expiration, subject to the plan’s standard terms and conditions.
Why did ClearSign (CLIR) grant stock options to Lou Basenese?
The options were granted as compensation for Basenese’s services as a non-employee director for the quarter ended June 30, 2026. They were issued under ClearSign’s Amended and Restated 2021 Equity Incentive Plan in line with the non-employee director compensation policy.
How many ClearSign (CLIR) options does Lou Basenese hold after this grant?
After this transaction, Lou Basenese holds 4,595 non-statutory stock options directly. These options are all tied to ClearSign common shares, are fully vested, and remain outstanding until their scheduled expiration date on June 29, 2036, unless exercised earlier.
AI-generated analysis. How Rhea-AI works. Not financial advice.
